Major drug makers are looking for products by purchasing smaller companies, creating many value opportunities, Barron's reported in its Jan. 31 edition.
Among the companies that Barron's singled out were Acorda, AMAG Pharmaceuticals, Alexion, BioMarin, Cadence, Cephalon, Cubist , Dendreon, Human Genome, Jazz Pharma , Onyx, United Therapeutics, and Salix Pharmaceuticals.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
